Alpha terpineol preconditioning enhances regenerative potential of mesenchymal stem cells in full thickness acid burn wounds
Regenerative Therapy · 2024-06 · 26 · 188-202
DOI: 10.1016/j.reth.2024.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Therapy, 2024-06. Verfasst von Fatima Jameel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Research Laboratory, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Science…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Higher Education Commission Pakistan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell Research Laboratory, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
- Department of Pharmacy, The University of Jordan, Amman, 11942, Jordan.
Förderung
- Higher Education Commission Pakistan
Zitieren
APA
Jameel, F., Irfan, F., Salim, A., Khan, I., & Khalil, E. A. (2024). Alpha terpineol preconditioning enhances regenerative potential of mesenchymal stem cells in full thickness acid burn wounds. Regenerative Therapy, 26, 188-202. https://doi.org/10.1016/j.reth.2024.05.008
Vancouver
Jameel F, Irfan F, Salim A, Khan I, Khalil EA. Alpha terpineol preconditioning enhances regenerative potential of mesenchymal stem cells in full thickness acid burn wounds. Regenerative Therapy. 2024;26:188-202. doi:10.1016/j.reth.2024.05.008
BibTeX
@article{Jameel2024,
author = {Jameel, Fatima and Irfan, Fatima and Salim, Asmat and Khan, Irfan and Khalil, Enam A},
title = {Alpha terpineol preconditioning enhances regenerative potential of mesenchymal stem cells in full thickness acid burn wounds},
journal = {Regenerative Therapy},
year = {2024},
volume = {26},
pages = {188--202},
doi = {10.1016/j.reth.2024.05.008}
}
EUVIMED